Det får ingen konsekvenser for anvendelsen af Taxotere/ Docetaxel Winthrop til de godkendte indikationer, for hvilke benefit/ risk- forholdet forbliver uændret.
There are no consequences on the use of Taxotere/ Docetaxel Winthrop in its authorised indications, for which the balance of benefits and risks remains unchanged.